FindTrial
Sign In

A study to compare standard 12 core TRUS prostate biopsy and MRI Fusion biospy to detect prostate cancer

COMPARISON OF STANDARD 12 CORES SYSTEMATIC TRUS GUIDED BIOPSY AND MRI-FUSION BIOPSY IN THE DETECTION OF PROSTATE CANCER ‰?? A PROSPECTIVE RANDOMIZED STUDY

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/04/024855
Enrollment
180
Registered
2020-04-25
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N429- Disorder of prostate, unspecified

Interventions

Intervention1: MRI-TRUS FUSION BIOPSY: NEWER TECHNIQUE IN THE DETECTION OF PROSTATE CANCER Control Intervention1: 12 CORE TRUS BIOPSY: STANDARD TECHNIQUE IN THE DETECTION OF PROSTATE BIOPSY

Sponsors

HRD SCHEME OF DHR for Young scientist
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients with elevated S.PSA level of 4-11 ng/ml 2.Suspected stage 3.Signed informed consent

Exclusion criteria

Exclusion criteria: 1.Patients in whom MRI is contraindicated or not feasible 2.Previous history of prostate biopsy, prostate surgery or treatment of prostate cancer 3.Patients with active urinary tract infection 4.Patients with diffuse hard nodular prostate 5.Patients refusing participation in the study

Design outcomes

Primary

MeasureTime frame
To evaluate the additional contribution by MRI-TRUS fusion targeted biopsy versus the standard 12 cores systematic TRUS guided biopsy in prostate cancer detectionTimepoint: 18 MONTHS—

Secondary

MeasureTime frame
1.Patients in whom MRI is contraindicated or not feasible 2. Previous history of prostate biopsy, prostate surgery or treatment of prostate cancer 3.Patients with active urinary tract infection 4.Patients with diffuse hard nodular prostate 5.Patients refusing participation in the study Timepoint: 18 MONTHS—

Countries

India

Contacts

Public ContactDR SRIDHAR P

AIIMS

amlesh.seth@gmail.com9868397433

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026